UK Clarifies RWD Collection Rules Under Early Access Scheme
Executive Summary
New UK guidance says companies do not have to apply for clinical trial approval or ethics review to collect data on the clinical management of patients receiving unapproved drugs under an early access scheme. However, consent is needed where such data may have research value once collected.